Statin therapy

Area of Science:

• Cardiology
• Pharmacology
• Vascular Medicine

Background:

• 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are primarily prescribed for dyslipidemia.
• Statins possess significant pleiotropic effects that reduce cardiovascular morbidity.
• Evidence suggests statins may be underutilized in patients undergoing cardiac surgical procedures.

Purpose of the Study:

• To review the periprocedural and long-term cardiovascular benefits of statin therapy in patients undergoing cardiac surgical procedures and percutaneous coronary interventions.
• To explore the proposed mechanisms underlying statin's cardioprotective effects.
• To highlight the need for further research on optimal statin therapy protocols in surgical contexts.

Main Methods:

• Literature review and synthesis of existing research on statin use in cardiovascular procedures.
• Analysis of studies reporting short-term and long-term outcomes.
• Examination of proposed mechanisms of action, including endothelial function, anti-inflammatory properties, and plaque stabilization.

Main Results:

• Statins demonstrate significant periprocedural benefits in both short-term and long-term follow-up for cardiac surgery and percutaneous coronary interventions.
• Key mechanisms include improved endothelial function, anti-inflammatory effects, and atherosclerotic plaque stabilization.
• Despite known side effects, the cardiovascular benefits of statins are well-established.

Conclusions:

• Statins provide clear cardiovascular benefits in patients undergoing cardiac procedures.
• Further research is essential to define optimal preoperative statin therapy, including patient selection, dosage, and duration.
• Investigating the impact of postoperative statin administration is also warranted.